The head-to-head SURMOUNT-5 data leaves no room for debate: tirzepatide outperforms semaglutide for weight loss in the same patient population
At best, theyll do nothing, but at worst could have potential side effects or cause delayed access to truly effective, medically supervised care
Past medical history should address previous gastrointestinal conditions, bleeding episodes, liver disease, and colorectal cancer screening status
Aurora said Id notice a difference, and yep, totally do
Special Considerations for Different Groups People With Kidney Disease Research shows mixed results in people with severe kidney disease
Alternative Weight Loss Approaches During the Breastfeeding Period If your healthcare provider advises against semaglutide while breastfeeding, evidence-based alternatives exist for postpartum weight management